Showing results (161-170 of 776) with videos related to

Sort By:
Pageof 78
Clinical Journal of the American Society of Nephrology : CJASN|February 8, 2023
Effects of Octreotide-Long-Acting Release Added-on Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease: Pilot, Randomized, Placebo-Controlled, Cross-Over TrialMatias Trillini, Anna Caroli, Norberto Perico, et al.
Nature Reviews. Nephrology|October 27, 2009
Transplantation: time to rethink immunosuppression by mTOR inhibitors?Marcus D Säemann, Giuseppe Remuzzi
BMC Nephrology|July 13, 2016
Diets for patients with chronic kidney disease, should we reconsider?William E Mitch, Giuseppe Remuzzi
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 13, 2004
Performance of different prediction equations for estimating renal function in kidney transplantationFlavio Gaspari, Silvia Ferrari, Nadia Stucchi, et al.
Journal of the American Society of Nephrology : JASN|September 7, 2014
Paricalcitol for secondary hyperparathyroidism in renal transplantationMatias Trillini, Monica Cortinovis, Piero Ruggenenti, et al.
Kidney International|August 13, 2010
Sirolimus for calcineurin inhibitors in organ transplantation: contraPaolo Cravedi, Piero Ruggenenti, Giuseppe Remuzzi
Journal of the American Society of Nephrology : JASN|December 25, 2003
Transplant renal artery stenosisSimona Bruno, Giuseppe Remuzzi, Piero Ruggenenti
Current Opinion in Nephrology and Hypertension|April 13, 2006
Progression of chronic kidney disease: insights from animal modelsCarla Zoja, Mauro Abbate, Giuseppe Remuzzi
Pageof 78